chartexchange

MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire Inc. | Nov 4, 2026 7:00 AM EST

ZUG, Switzerland, November 4, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) ("MoonLake" or the "Company"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today provided a business update and reported third quarter 2026 financial results.

Read original article